
Pharmagreen Biotech
(OTC) PHBI
Pharmagreen Biotech Financials at a Glance
Market Cap
$1.19M
Revenue (TTM)
$3.42M
Net Income (TTM)
$557.02K
EPS (TTM)
$-0.00
P/E Ratio
-4.50
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$0.00
Volume
50,488
Open
$0.00
Price
$0.00
Volume
50,488
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$0.00
Volume
50,488
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PHBI News
PHBI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharmagreen Biotech
Industry
Pharmaceuticals
Sector
Health CareCEO
Peter Wojcik
Website
www.pharmagreen.caHeadquarters
Coquitlam, BC V3E 3A2, CA
PHBI Financials
Key Financial Metrics (TTM)
Gross Margin
-0%
Operating Margin
-37%
Net Income Margin
-16%
Return on Equity
0%
Return on Capital
14%
Return on Assets
-94%
Earnings Yield
-22.22%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.19M
Shares Outstanding
663.65M
Volume
50.49K
Short Interest
0.00%
Avg. Volume
2.22M
Financials (TTM)
Gross Profit
$1.74K
Operating Income
$248.00K
EBITDA
$971.18K
Operating Cash Flow
$28.09K
Capital Expenditure
$4.00
Free Cash Flow
$28.09K
Cash & ST Invst.
$276.00
Total Debt
$356.24K
Pharmagreen Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.42M
+682948.3%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$1.19M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.10M
-41.4%
EBITDA
$1.12M
-45.8%
Quarterly Fundamentals
Net Cash
$261.80K
+26.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$266.07K
+0.2%
Return on Assets
-94.08%
N/A
Return on Invested Capital
13.71%
N/A
Free Cash Flow
$3.82K
-487.7%
Operating Cash Flow
$3.82K
-484.3%